参考文献/References:
[1] WOLF D,LEY K.Immunity and inflammation in atherosclerosis[J].Circ Res,2019,124(2):315-327.
[2] FROSTEG ARD J.Immunity,atherosclerosis and cardiovascular disease[J].BMC Med,2013,11:117.
[3] 中国心血管健康与疾病报告2019[J].心肺血管病杂志,2020,39(10):1157-1162.
[4] KOBIYAMA K,LEY K.Atherosclerosis[J].Circ Res,2018,123(10):1118-1120.
[5] GEOVANINI G R,LIBBY P.Atherosclerosis and inflammation:overview and updates[J].Clin Sci (Lond),2018,132(12):1243-1252.
[6] SOEHNLEIN O,LIBBY P.Targeting inflammation in atherosclerosis-from experimental insights to the clinic[J].Nat Rev Drug Discov,2021,epub ahead of print.DOI:10.1038/s41573-021-00198-1.
[7] LIBBY P.Interleukin-1 beta as a target for atherosclerosis therapy:biological basis of CANTOS and beyond[J].J Am Coll Cardiol,2017,70(18):2278-2289.
[8] AIT-OUFELLA H,LIBBY P,TEDGUI A.Anticytokine immune therapy and atherothrombotic cardiovascular risk[J].Arterioscler Thromb Vasc Biol,2019,39(8):1510-1519.
[9] BCK M,HANSSON G K.Anti-inflammatory therapies for atherosclerosis[J].Nat Rev Cardiol,2015,12(4):199-211.
[10] LI P,PAN G P,JIA M,et al.Effect of Xin Mai Jia on atherosclerosis in rats[J].Genet Mol Res,2015,14(2):6018-6027.
[11] WAN J,YIN Y,SUN R,et al.Protective effect of the ultra-filtration extract from Xin Mai Jia on human aortic smooth muscle cell injury induced by hydrogen peroxide[J].Exp Ther Med,2014,7(1):11-16.
[12] YIN Y,WAN J,LI P,et al.Protective effect of Xin Mai Jia ultrafiltration extract on human umbilical vein endothelial cell injury induced by hydrogen peroxide and the effect on the NO-cGMP signaling pathway[J].Exp Ther Med,2014,8(1):38-48.
[13] YIN Y L,ZHU M L,WAN J,et al.Traditional Chinese medicine xin-mai-jia recouples endothelial nitric oxide synthase to prevent atherosclerosis in vivo[J].Sci Rep,2017,7:43508.
[14] 王作敏,薛金涛,荆云,等.心脉佳Ⅰ胶囊的质量标准研究[J].新乡医学院学报,2017,34(2):107-109.
[15] SONG P,FANG Z,WANG H,et al.Global and regional prevalence,burden,and risk factors for carotid atherosclerosis:a systematic review,meta-analysis,and modelling study[J].Lancet Glob Health,2020,8(5):e721-e729.
[16] ZHAO F R,LU J X,JIA M,et al.Effects and mechanism of Xin Mai Jia in a rabbit model of atherosclerosis[J].Exp Ther Med,2015,10(5):1627-1634.
[17] TABAS I,BORNFELDT K E.Macrophage phenotype and function in different stages of atherosclerosis[J].Circ Res,2016,118(4):653-667.
[18] JINNOUCHI H,GUO L,SAKAMOTO A,et al.Diversity of macrophage phenotypes and responses in atherosclerosis[J].Cell Mol Life Sci,2020,77(10):1919-1932.
[19] WINKLER S,RSEN-WOLFF A.Caspase-1:an integral regulator of innate immunity[J].Semin Immunopathol,2015,37(4):419-427.
[20] RATHINAM V A K,ZHAO Y,SHAO F.Innate immunity to intracellular LPS[J].Nat Immunol,2019,20(5):527-533.
[21] SWANSON K V,DENG M,TING J P.The NLRP3 inflammasome:molecular activation and regulation to therapeutics[J].Nat Rev Immunol,2019,19(8):477-489.
相似文献/References:
[1]张 敏,李雪琴,马增凤.血清脂质水平测定在肾脏疾病中的意义[J].新乡医学院学报,2000,17(05):346.
[2]张 敏,李雪琴,马增凤.血清脂质水平测定在肾脏疾病中的意义[J].新乡医学院学报,2000,17(05):346.
[3]周延升,李聪辉,李平法,等.维生素对大鼠脂质及脂质过氧化作用的影响[J].新乡医学院学报,2002,19(02):081.
[4]王淑秀,赵长安,许春雷,等.同型半胱氨酸对内皮细胞单核细胞趋化蛋白一1表达的影响[J].新乡医学院学报,2003,20(02):086.
[5]王淑秀,赵长安,许春雷,等.同型半胱氨酸对内皮细胞单核细胞趋化蛋白O1 表达的影响[J].新乡医学院学报,2003,20(02):086.
[6]王淑秀,赵长安,和瑞芝.同型半胱氨酸诱导内皮细胞表达白细胞介素8[J].新乡医学院学报,2003,20(03):158.
[7]李西兴,周延升,时 岚,等.血脂和同型半胱氨酸对家兔动脉粥样硬化形成的影响[J].新乡医学院学报,2003,20(01):005.
[8]李西兴,周延升,时.岚,等.血脂和同型半胱氨酸对家兔动脉粥样硬化形成的影响[J].新乡医学院学报,2003,20(01):005.
[9]徐自超,张哲莹,郭晓静,等.核转录因子-κB在动脉粥样硬化大鼠动脉平滑肌细胞中的表达[J].新乡医学院学报,2009,26(03):235.
[10]张林静,郭金敏,何玉惠,等.沙利度胺抑制动脉粥样硬化的临床效应[J].新乡医学院学报,2014,31(10):809.[doi:10.7683/xxyxyxb.2014.10.011]